Anindita (Annie) Saha is associate director for strategic initiatives for the Digital Health Center of Excellence (DHCoE) in the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration (FDA) where she supports promoting innovation of digital health technologies, including those enabled by AI. She is also serving as the acting associate director for data science and AI policy at the FDA Center for Drug Evaluation and Research (CDER) to support the use of AI across the drug development lifecycle. Additionally, Saha helped incubate and continues to support to advance the science and adoption of patient input as evidence, including patient preference information (PPI) and clinical outcome assessments (COAs).

Previously, Saha was the director of the Partnerships team in CDRH where she oversaw a broad program portfolio, supporting several strategic partnership and regulatory science programs. Saha started at FDA as a researcher in the Office of Science and Engineering Laboratories in imaging display technologies. She has a BS in bioengineering and minor in history from the University of Pittsburgh.